Assessment of humoral immunity to SARS-CoV-2 among employees of medical organizations in the Republic of Tatarstan

Author:

Minullin Iskander K.ORCID,Eremeeva Zhanna G.ORCID,Bogdanova Elena V.ORCID,Iskandarov Ildar R.ORCID,Safina Elvira I.ORCID

Abstract

BACKGROUND: Since the beginning of the new coronavirus infection pandemic, preventive measures aimed at combating the spread of the pathogen and preventing the development of severe forms of infection and deaths have improved. Despite the absence of a legally established, generally accepted post-vaccination protective value of antibodies to coronavirus, the study of the presence of antibodies and the determination of their amount in the blood serum of the vaccinated population continues. AIM: This study presents the results of post-vaccination humoral immunity to SARS-CoV-2 in medical organizations regardless of their infectious disease history. MATERIALS AND METHODS: This study involved employees of medical organizations of the State Autonomous Health Institution Republican Clinical Dermatovenerologic Dispensary of the Ministry of Health of the Republic of Tatarstan named after Professor A.G. Ge in Kazan and the State Autonomous Health Institution City Polyclinic No. 3 in Naberezhnye Chelny. Three hundred ninety-three people (including 350 women) were vaccinated with the two-component vaccine GamCovidVac (Sputnik V). After a sufficient amount of time passed for the formation of an immune response, more than 21 days. The blood sera of these 393 people were examined for the determination of specific IgG to SARS-CoV-2 by enzyme immunoassay using the Vector-Best kit (Novosibirsk, Russia). Statistical analysis was performed using StatTech v.3.0.9 (developer, Stattech LLC, Russia). RESULTS: The median age of the subjects was 47 (Q1Q3: 3959) years. The mean antibody titer level was 570 (Q1Q3: 1281150 BAU/ml). A correlation analysis of the relationship between titer levels and age at the time of vaccination was performed. According to the results, a weak direct relationship was established. There was no connection when assessing the antibody titer level dependence on vaccination duration after the second component at the time of checking the titers. CONCLUSIONS: The ongoing pandemic of a new coronavirus infection with the emergence of new forms of the disease caused by other virus strains, the improvement in prevention methods, requires constant monitoring of the epidemiological situation with the study of the vaccine effectiveness, including the cellular level.

Publisher

ECO-Vector LLC

Subject

Building and Construction

Reference10 articles.

1. On the state of sanitary and epidemiological well-being of the population in the Republic of Tatarstan in 2021: state report. Kazan: Federal Service for Supervision of Consumer Rights Protection and Human Welfare; 2022. 359 p. (In Russ).

2. Prikaz Ministerstva zdravookhraneniya Rossiyskoy Federatsii ot 06.12.2021 № 1122n “Ob utverzhdenii natsional’nogo kalendarya profilakticheskikh privivok, kalendarya profilakticheskikh privivok po epidemicheskim pokazaniyam i poryadka provedeniya profilakticheskikh privivok” [Order of the Ministry of Health of the Russian Federation dated December 6, 2021 No. 1122n “On approval of the national calendar of preventive vaccinations, the calendar of preventive vaccinations according to epidemic indications and the procedure for conducting preventive vaccinations”] [Internet]. Available from: http://publication.pravo.gov.ru/Document/View/0001202112200070 Accessed: Feb 16, 2023. (In Russ).

3. Garmash YuYu, Ivanova DA, Borisov SE. Monitoring of antibodies to SARS-CoV-2 in workers of anti-tuberculosis hospital. Tuberculosis and Socially Significant Diseases. 2021;(1):21–31. (In Russ).

4. Immunity to Vaccine-Preventable Infections in Healthcare Professionals Working in Infectious Diseases Hospitals

5. Features of humoral immunity after COVID-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3